Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples